Beckman Coulter Life Sciences and Automata announced a strategic partnership integrating Beckman liquid‑handling and analytic instrumentation into Automata’s LINQ AI‑ready automation ecosystem; Danaher Ventures joined Automata’s Series C and the companies signaled deeper collaboration. Separately, Automata closed $45 million in Series C financing that included Danaher’s strategic investment. The alliance maps lab automation hardware into cloud‑native orchestration and unified scheduling software, aiming to produce structured, high‑quality datasets for AI‑driven discovery. The funding and Beckman tie bring capital, channel access, and validation that could accelerate adoption of closed‑loop, autonomous wet‑lab workflows in biotech R&D and biomanufacturing.